Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lifesol
- Development stage
- Unknown
- Lead developer
- Geofman Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Lifesol is a brand of intravenous infusion solutions manufactured by Geofman Pharmaceuticals. The Lifesol product line includes various formulations used for fluid resuscitation, electrolyte replenishment, and caloric support. These formulations include Lifesol 0.9% (Sodium Chloride injection), Lifesol 5%, 10%, and 25% (Dextrose infusions), as well as combination solutions such as Lifesol 5% + 0.9% NaCl (Dextrose and Sodium Chloride injection). These solutions are indicated for maintaining or restoring sodium and electrolyte balance, treating dehydration, and providing immediate caloric energy via intravenous administration.
- Brand names
- Lifesol
- Other names
- dextrosesodium chloride
Beyond the preview
Go deeper on Lifesol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lifesol.